Drugs / VSLI
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01319981 | Mar 2013 → Nov 2020 | leukemia | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VSLI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01319981 ↗ |
| Route | Intravenous | “2.0 mg/m2 by vein on day 1 and day 8” NCT01319981 ↗ |